Old Web
English
Sign In
Acemap
>
authorDetail
>
L. Agate
L. Agate
Medicine
Thyroid cancer
Mutation
5 year follow up
Cancer research
4
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Ret somatic mutations are not an early event in the tumoral transformation of sporadic medullary thyroid cancer
2012
Cristina Romei
Barbara Cosci
Clara Ugolini
Valeria Bottici
E Molinaro
L. Agate
Alessia Tacito
F. Basolo
Paolo Miccoli
Aldo Pinchera
R Elisei
Show All
Source
Cite
Save
Citations (0)
La tempistica dell’intervento di tiroidectomia totale nei portatori di mutazioni del gene RET potrebbe essere personalizzata e programmata con sicurezza sulla base dei livelli sierici di calcitonina: 18 anni di esperienza in un singolo centro
2012
R Elisei
Cristina Romei
Giulia Renzini
V Bottici
Barbara Cosci
E Molinaro
L. Agate
Virginia Cappagli
Paolo Miccoli
Piero Berti
Pinuccia Faviana
Clara Ugolini
Fulvio Basolo
P. Vitti
A. Pinchera
Fabio Lanfranco
Matteo Baldi
Show All
Source
Cite
Save
Citations (0)
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated thyroid cancer patients: a 5 year follow up study
2012
David Viola
Liborio Torregrossa
Riccardo Giannini
Clara Ugolini
A. Biagini
Cristina Romei
E Molinaro
L. Agate
F. Basolo
A. Pinchera
P. Vitti
R Elisei
Show All
Source
Cite
Save
Citations (0)
Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study.
2011
David Viola
Riccardo Giannini
Clara Ugolini
A. Biagini
Cristina Romei
E Molinaro
L. Agate
F. Basolo
A. Pinchera
R Elisei
Show All
Source
Cite
Save
Citations (1)
1